Inventor · disambiguated record
Holia Hatoum-Mokdad
Also filed as: HATOUM-MOKDAD HOLIA · HATOUM-MOKDAD HOLIA N
11 granted patents·18 pending applications·239 citations·filing 1999–2012
92Inventor score
Top patents by PatentIndex Score
29 records- 0196US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0294US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0391US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 0486US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 0586US6943172B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 13, 2005·20 cites·5 claims
- 0686US6903101B1Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activityBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Jun 7, 2005·21 cites·22 claims
- 0786US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 0880US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 0980US6924290B2Rho-kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Aug 2, 2005·14 cites·17 claims
- 1067US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 1166US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 1261US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 1359US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1459US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1558US2009093526A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2007·Application pending·0 cites
- 1655US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1753US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 1853US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 1952US2012270878A1Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasMILLER SCOTT·Filed 2012·Application pending·0 cites
- 2051US2005192304A1Rho-kinase inhibitorsFiled 2005·Application pending·0 cites
- 2151US2012302587A1Rho-kinase inhibitorsNAGARAHNAM DHANAPALAN·Filed 2012·Application pending·0 cites
- 2250US2010137313A1Heterocyclic derivatives and methods of use thereofASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2349US2005209261A1Rho-kinase inhibitorsNAGARATHNAM DHANAPALAN·Filed 2005·Application pending·0 cites
- 2447US2012053179A1Rho-Kinase InhibitorsNAGARATHNAM DHANAPALAN·Filed 2011·Application pending·0 cites
- 2547US2012149706A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 2646US2006063760A1Hydroxamic acids useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 2745US2011195110A1Urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2006·Application pending·0 cites
- 2840US2003207914A1Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER AG·Filed 2002·Application pending·0 cites
- 2938US2002065296A1Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holia Hatoum-Mokdad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →